Document:

SECURITIES
PURCHASE AGREEMENT

 

THIS
SECURITIES PURCHASE AGREEMENT (this “Agreement”), is made as of this _______day of September, 2017 by and among Croe,
Inc., a Utah corporation (the “Company”), and the undersigned Purchaser (the “Purchaser”).

 

The
parties hereby agree as follows:

 

1.
Purchase and Sale of Common Stock and Warrant.

 

1.1.
Sale and Issuance of Common Stock and Warrant. Subject to the terms and conditions of this Agreement, the Purchaser agrees
to purchase at the Closing and the Company agrees to sell and issue to the Purchaser at the Closing (i) that number of shares
of common stock of the Company, par value $0.001 per share (the “Common Stock”), set forth on the signature
page hereto at a price of $2.00 per share; and (ii) a stock purchase warrant (the “Warrant”) to purchase that
number of shares of Common Stock set forth on the signature page hereto, equal to 25% of the shares to purchased pursuant to clause
(i), at a price of $2.00 per share. The shares of Common Stock issued to the Purchaser pursuant to this Agreement shall be referred
to in this Agreement as the “Shares”, and together with the Warrant, the “Securities”.

 

1.2.
Closing; Delivery.

 

(a)
The initial purchase and sale of the Securities shall take place remotely via the exchange of documents and signatures as
soon as practicable following the execution of this Agreement for an aggregate subscription by the Purchaser, at such time
and place upon which the Company and the Purchaser mutually agree, orally or in writing (which time and place are designated
as the “Initial Closing”). The term “Closing” shall apply to the Initial Closing and
each subsequent closing unless otherwise specified.

 

(b)
Each subsequent purchase and sale of the Securities shall take place as soon as practicable following the execution of this
Agreement for each additional subscription by one or more Purchasers for an aggregate of up to $2,000,000, which amount may
be increased by the Company in its sole discretion, at such other time and place upon which the Company and the Purchasers
mutually agree, orally or in writing.

 

(c)
At each Closing, the Company shall deliver to the Purchaser a certificate representing the Shares and the Warrant being
purchased by the Purchaser at such Closing against payment of the purchase price therefor by wire transfer of immediately
available funds to the bank account designated by the Company.

 

1.3.
Use of Proceeds. The Company will use a portion of the proceeds to capitalize the Company’s cryptocurrency portfolio,
and the remainder for working capital and other general corporate purposes in accordance with the directions of the Company’s
Board of Directors.

 

1.4.
Defined Terms Used in this Agreement. In addition to the terms defined above, the following terms used in this Agreement
shall be construed to have the meanings set forth or referenced below.

 

(a)
“Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly, controls,
is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member,
officer or director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more general
partners or managing members of, or shares the same management company with, such Person.

 

    	 

    	 

    

 

(b)
“Articles” means the Articles of Incorporation of the Company, as amended and restated from time to time.

 

(c)
“Code” means the Internal Revenue Code of 1986, as amended.

 

(d)
“Company Covered Person” means, with respect to the Company as an “issuer” for purposes of Rule
506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

(e)
“Company Intellectual Property” means all patents, patent applications, trademarks, trademark applications,
service marks, service mark applications, tradenames, copyrights, trade secrets, domain names, mask works, information and proprietary
rights and processes, similar or other intellectual property rights, subject matter of any of the foregoing, tangible embodiments
of any of the foregoing, licenses in, to and under any of the foregoing, and any and all such cases that are owned or used by
the Company in the conduct of the Company’s business as now conducted and as presently proposed to be conducted.

 

(f)
“Knowledge” including the phrase “to the Company’s knowledge” shall mean the actual
knowledge after reasonable investigation of its officers and directors.

 

(g)
“Material Adverse Effect” means any change or event that has a material adverse effect, in magnitude or duration,
on the business, assets (including intangible assets), liabilities, financial condition, property, prospects or results of operations
of the Company, taken as a whole, other than any change, effect or event to the extent resulting from, relating to or arising
out of: (i) general business or economic conditions in any of the markets or geographical areas in which the Company operates;
(ii) any change in economic conditions or the financial, credit, banking, interest rate, currency or capital markets in general
(whether in the United States or any other country or in any international market); (iii) any conditions generally affecting any
industry in which the Company operates; or (iv) acts of God or other calamities, national or international political or social
conditions.

 

(h)
“Person” means any individual, corporation, partnership, trust, limited liability company, association or other
entity.

 

(i)
“Purchaser” means the Purchaser who is a party to this Agreement.

 

(j)
“Securities” means the Shares and the Warrant, collectively.

 

(k)
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

(l)
“Shares” means the shares of Common Stock issued at the Closing.

 

(m)
“Taxes” means all federal, state, local, foreign and other income, gross receipts, sales, use, production,
ad valorem, transfer, franchise, registration, profits, license, lease, service, service use, withholding, payroll, employment,
unemployment, estimated, excise, severance, environmental, stamp, occupation, premium, property (real or personal), real property
gains, windfall profits, customs, duties or other taxes, fees, assessments or charges of any kind whatsoever, together with any
interest, additions or penalties with respect thereto and any interest in respect of such additions or penalties.

 

(n)
“Warrant” means the common stock purchase warrant issued at the Closing.

 

    	2

    	 

    

 

2.
Representations and Warranties of the Company. The Company hereby represents and warrants to the Purchaser that the following
representations are true and complete as of the date of the Closing, except as otherwise indicated.

 

2.1.
Organization, Good Standing, Corporate Power and Qualification. The Company is a corporation duly organized, validly existing
and in good standing under the laws of the State of Utah and has all requisite corporate power and authority to carry on its business
as presently conducted and as proposed to be conducted. The Company is duly qualified to transact business and is in good standing
in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.

 

2.2.
Capitalization.

 

(a)
The authorized capital of the Company consists, immediately prior to the Closing, of (i) 50,000,000 shares of common stock, par
value $0.001 per share, approximately 18,877,911 shares of which are issued and outstanding, and (ii) 10,000,000 shares of preferred
stock, par value $0.001 per share, none of which are outstanding. All of the outstanding shares of Common Stock have been duly
authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws.

 

(b)
The Company has reserved 5,000,000 shares of Common Stock for issuance to officers, directors, employees and consultants of the
Company pursuant to its 2017 Equity Incentive Plan duly adopted by the Board of Directors.

 

2.3.
Authorization. All corporate action required to be taken by the Company’s Board of Directors and stockholders in
order to authorize the Company to enter into this Agreement, and to issue the Securities at the Closing, has been taken or will
be taken prior to the Closing. All action on the part of the officers of the Company necessary for the execution and delivery
of this Agreement, the performance of all obligations of the Company under this Agreement to be performed as of the Closing, and
the issuance and delivery of the Securities has been taken or will be taken prior to the Closing. This Agreement, when executed
and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company
in accordance its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance,
or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, and (ii) as
limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

2.4.
Valid Issuance of Securities. The Securities, when issued, sold and delivered in accordance with the terms and for the
consideration set forth in this Agreement, and the shares of Common Stock issuable upon exercise of the Warrant, will be validly
issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under applicable
state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the
representations of the Purchaser in Section 3 of this Agreement, the Securities will be issued in compliance with all applicable
federal and state securities laws.

 

2.5.
Governmental Consents and Filings. Assuming the accuracy of the representations made by the Purchaser in Section 3
of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or
filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the
consummation of the transactions contemplated by this Agreement, except for filings pursuant to Regulation D of the Securities
Act, and applicable state securities laws, which have been made or will be made in a timely manner.

 

    	3

    	 

    

 

2.6.
Litigation. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation (each, an “Action”)
pending or to the Company’s knowledge, currently threatened (i) against the Company or its Affiliates, or (ii) against any
officer or director of the Company arising out of their employment or board relationship with the Company or its Affiliates; or
(iii) that questions the validity this Agreement or the right of the Company to enter herein, or to consummate the transactions
contemplated hereby; or (iv) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse
Effect. No event has occurred or circumstances exist that may give rise to, or serve as a basis for, any such Action. Neither
the Company nor any of its Affiliates nor, to the Company’s knowledge, any of their respective officers or directors is
a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government
agency or instrumentality (in the case of officers or directors, such as would affect the Company). There is no action, suit,
proceeding or investigation by the Company pending or which the Company intends to initiate.

 

2.7.
Compliance with Other Instruments. The Company is not in violation or default (i) of any provisions of its Articles or
Bylaws, (ii) of any instrument, judgment, order, writ or decree, (iii) under any lease, agreement, contract or purchase order
to which it is a party or by which it is bound, or (iv) of any provision of federal or state statute, rule or regulation applicable
to the Company, the violation of which would have a Material Adverse Effect. The execution, delivery and performance of this Agreement
and the consummation of the transactions contemplated hereby will not result in any such violation or be in conflict with or constitute,
with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment,
order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance
upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable
to the Company.

 

2.8.
Property. The property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans
and encumbrances, except for statutory liens for the payment of current Taxes that are not yet delinquent and encumbrances and
liens that arise in the ordinary course of business and do not materially impair the Company’s ownership or use of such
property or assets. With respect to the property and assets it leases, the Company is in compliance with such leases and, to its
knowledge, holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such
property or assets. The Company does not own any real property.

 

2.9.
Tax Returns and Payments. There are no federal, state, county, local or foreign Taxes due and payable by the Company which
have not been timely paid. There are no accrued and unpaid federal, state, country, local or foreign Taxes of the Company which
are due, whether or not assessed or disputed. No claim has been made by any taxing authority in any jurisdiction where the Company
does not file Tax returns that it is, or may be, subject to Tax by that jurisdiction. There have been no examinations or audits
of any Tax returns or reports by any applicable federal, state, local or foreign governmental agency.

 

2.10.
Corporate Documents. The Articles and Bylaws of the Company have been provided to the Purchaser. The copy of the minute
books of the Company provided to the Purchaser contains minutes of all meetings of directors and stockholders and all actions
by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects
in all material respects all actions by the directors (and any committee of directors) and stockholders with respect to all transactions
referred to in such minutes.

 

2.11.
Disclosure. The Company has made available to the Purchaser all the information reasonably available to the Company that
the Purchaser has requested for deciding whether to acquire the Securities. No representation or warranty of the Company contained
in this Agreement contains any untrue statement of a material fact or omits to state a material fact necessary in order to make
the statements contained herein or therein not misleading in light of the circumstances under which they were made.

 

    	4

    	 

    

 

3.
Representations and Warranties of the Purchaser. The Purchaser hereby represents and warrants to the Company that:

 

3.1.
Authorization. The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and
delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable in accordance
with their terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and
any other laws of general application affecting enforcement of creditors’ rights generally, and as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies.

 

3.2.
Purchase Entirely for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation
to the Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities
to be acquired by the Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent,
and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling,
granting any participation in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents
that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer
or grant participations to such Person or to any third Person, with respect to any of the Securities. The Purchaser has not been
formed for the specific purpose of acquiring the Securities.

 

3.3.
Sophisticated Investor. The Purchaser is a sophisticated investor by virtue of the Purchaser’s education, training
and numerous prior investments made on the Purchaser’s own behalf or through entities which the Purchaser controls. The
Purchaser is knowledgeable and experienced in financial and business matters and is capable of evaluating the merits and risks
of an investment in the Securities and has the capacity to protect the Purchaser’s own interests in connection with
the purchase of the Securities, either alone or in conjunction with the Purchaser’s professional advisers, who are
unaffiliated with and who are not compensated, directly or indirectly, by the Company or any affiliate of the Company. All information
that the Purchaser has provided to the Company concerning the Purchaser and the Purchaser’s financial position is correct
and complete.

 

3.4.
Disclosure of Information. The Purchaser has had an opportunity to discuss the Company’s business, management, financial
affairs and the terms and conditions of the offering of the Securities with the Company’s management and has had an opportunity
to review the Company’s facilities. The foregoing, however, does not limit or modify the representations and warranties
of the Company in Section 2 of this Agreement or the right of the Purchaser to rely thereon.

 

3.5.
Restricted Securities. The Purchaser understands that the Securities have not been, and will not be, registered under the
Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among
other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed
herein. The Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal and
state securities laws and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered
with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification
requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Securities
for resale. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be
conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Securities,
and on requirements relating to the Company which are outside of the Purchaser’s control, and which the Company is under
no obligation and may not be able to satisfy.

 

    	5

    	 

    

 

3.6.
Legends. The Purchaser understands that the Securities and any securities issued in respect of or exchange for the Securities,
may be notated with one or all of the following legend:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS
NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”

 

3.7.
Accredited Investor. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under
the Securities Act.

 

3.8.
No General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or
partners has either directly or indirectly, including, through a broker or finder

(a)
engaged in any general solicitation, or (b) published any advertisement in connection with the offer and sale of the Securities.

 

3.9.
Purchasers Outside of the United States. The following representations and warranties apply only if the Purchaser not a
resident of the United States.

 

(a)
Certification Regarding U.S. Person Status. The Purchaser (i) is not a U.S. Person (as defined in Rule 902 of Regulation
S adopted by the Securities Exchange Commission pursuant to the Securities Act), is not acquiring the Securities for the account
or benefit of any U.S. Person, did not receive this Agreement or an offer to purchase the Securities in the United States and
did not execute this Agreement and pay the amounts specified hereunder from within the United States.

 

(b) Offshore
Transaction. The Purchaser acknowledges that the offer and sale of the Securities is not taking place within the
United States, but rather in an “offshore transaction,” as defined in Rule 902 of Regulation S adopted by
the Securities Exchange Commission pursuant to the Securities Act, and that no “directed selling efforts” took
place within the United States in compliance with Regulation S, unless the Purchaser is an Accredited Investor.

 

(c)
Compliance with USA Patriot Act and BSA. The Purchaser is in compliance with all applicable provisions of the Uniting
and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (the “USA
Patriot Act”), the U.S. Bank Secrecy Act (the “BSA”) and all other anti-money laundering laws and
applicable regulations adopted to implement the provisions of such laws, including policies and procedures that can be reasonably
expected to detect and cause the reporting of transactions under Section 5318 of the BSA. The Purchaser is not and shall not be
a person: (i) acting, directly or indirectly, on behalf of terrorists or terrorist organizations, including those persons or entities
that are included on any of the Office of Foreign Assets Control (OFAC) lists of the U.S. Department of the Treasury; (ii) listed
on, residing in or having a place of business in a country or territory named on any of such lists or which is designated as a
Non-Cooperative Jurisdiction by the Financial Action Task Force on Money Laundering (FATF), or whose funds are from or through
such a jurisdiction; (iii) that is a “Foreign Shell bank” within the meaning of the USA Patriot Act; or (iv) residing
in or organized under the laws of a jurisdiction designated by the U.S. Secretary of the Treasury under Sections 311 or 312 of
the USA Patriot Act as warranting special measures due to money-laundering concerns.

 

    	6

    	 

    

 

(d) Distribution
Compliance Period. Without limitation to the other restrictions on transfer referenced herein, if the Purchaser is (i) a
purchaser in a sale that occurs outside the United States within the meaning of Regulation S or (ii) a
“distributor,” “dealer” or person “receiving a selling concession, fee or other
remuneration” in respect of Securities sold, prior to the expiration of the applicable “distribution compliance
period” (as defined below), it acknowledges that (A) until the expiration of such “distribution compliance
period” any offer or sale of the Securities shall not be made by it to a U.S. Person or for the account or benefit of a
U.S. Person within the meaning of Rule 902(k) of the Securities Act and (B) until the expiration of the “distribution
compliance period,” it may not, directly or indirectly, refer, resell, pledge or otherwise transfer Securities or any
interest therein except to a person who certifies in writing to the Company that such transfer satisfies, as applicable, the
requirements of the legends described herein and that the Securities will not be accepted for registration of any transfer
prior to the end of the applicable “distribution compliance period” unless the transferee has first complied with
certification requirements described in this Section. The Purchaser agrees (1) that all offers or sales prior to the end of a
“distribution compliance period” will be made in accordance with Rule 903 or Rule 904 of the Securities Act and
(2) not to engage in any hedging transaction prior to the end of such “distribution compliance period.” The
“distribution compliance period” means the one-year period following the issue date for the
Securities.

 

4.
Conditions to the Purchaser’s Obligations at Closing. The obligations of the Purchaser to purchase Securities at
the Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived:

 

4.1.
Representations and Warranties. The representations and warranties of the Company contained in Section 2 shall be
true and correct in all respects as of the Closing.

 

4.2.
Performance. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained
in this Agreement that are required to be performed or complied with by the Company on or before the Closing.

 

4.3.
Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the
United States or of any state that are required in connection with the lawful issuance and sale of the Securities pursuant to
this Agreement shall be obtained and effective as of the Closing.

 

5.
Conditions of the Company’s Obligations at Closing. The obligations of the Company to sell the Securities to the
Purchaser at the Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless
otherwise waived:

 

5.1.
Representations and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall
be true and correct in all respects as of the Closing.

 

5.2.
Performance. The Purchaser shall have performed and complied with all covenants, agreements, obligations and conditions
contained in this Agreement that are required to be performed or complied with by them on or before the Closing.

 

5.3.
Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the
United States or of any state that are required in connection with the lawful issuance and sale of the Securities pursuant to
this Agreement shall be obtained and effective as of the Closing.

 

6.
Miscellaneous.

 

6.1. Survival
of Warranties. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the
Purchaser contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the
Closing and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on
behalf of the Purchaser or the Company.

 

    	7

    	 

    

 

6.2.
Indemnification.

 

(a)
The Company shall indemnify, defend, reimburse and hold harmless the Purchaser and its affiliates and their respective
officers, directors, trustees, agents, representatives, employees, stockholders, members, managers, partners and controlling
Persons (each, an “Indemnified Party”) against any and all Losses (as hereinafter defined) arising out of
or relating to any legal, administrative or other actions (including actions brought by the Purchaser or the Company or any
equity holders of the Company or any derivative actions brought by any Person claiming through or in the Company’s
name), proceedings or investigations (whether formal or informal), or written threats thereof, based upon, resulting from,
relating to or arising out of any misrepresentation or breach of any representation, warranty, covenant or agreement by the
Company in this Agreement.

 

(b)
In connection with the obligation of the Company to indemnify for expenses as set forth in Section 6.2(a) above, the
Company shall reimburse each Indemnified Party for all such expenses (including reasonable expenses of investigation and
reasonable fees, disbursements and other charges of counsel in connection with any claim, action, suit or proceeding) as they
are incurred by such Indemnified Party. “Losses” means all losses (including the diminution in the value
of the Securities purchased by Purchaser), claims (including any claim by a third party), damages, expenses (including
reasonable fees, disbursements and other charges of counsel incurred by the Indemnified Party in connection with any claim,
action, suit or proceeding, including any action between the Indemnified Party and the Company or between the Indemnified
Party and any third party) or other liabilities resulting from, relating to or arising out of any misrepresentation or breach
of any representation, warranty, covenant or agreement by the Company in this Agreement.

 

6.3.
Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the
respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement.

 

6.4.
Governing Law. This Agreement shall be governed by the internal law of the State of Nevada, regardless of the laws that
might otherwise govern under applicable principles of conflicts of law.

 

6.5.
Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic
mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid
and effective for all purposes.

 

6.6.
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement.

 

6.7.
Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be
deemed effectively given upon the earlier of actual receipt, or (a) personal delivery to the party to be notified, (b) when sent,
if sent by electronic mail or facsimile during normal business hours of the recipient, and if not sent during normal business
hours, then on the recipient’s next business day, (c) five (5) days after having been sent by registered or certified mail,
return receipt requested, postage prepaid, or (d) one (1) business day after deposit with a nationally recognized overnight courier,
freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent
to the respective parties at their address as set forth on the signature page, or to such e-mail address, facsimile number or
address as subsequently modified by written notice given in accordance with this Subsection 6.7. Notice sent to the Company
shall be sent to the following address:

 

    	8

    	 

    

 

Croe,
Inc.

23805
Stuart Ranch Road, Suite 235

Malibu,
CA 90265

Attn:
Chief Executive Officer

 

With
a copy to:

 

Drinker
Biddle & Reath LLP

1800 Century Park East, Ste 1500

Los Angeles, CA 90067

Attn:
Alan A. Lanis, Jr.

 

6.8.
No Finder’s Fees. Each party represents that it neither is nor will be obligated for any finder’s fee or commission
in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for
any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the
costs and expenses of defending against such liability or asserted liability) for which the Purchaser or any of its officers,
employees or representatives is responsible. The Company agrees to indemnify and hold harmless the Purchaser from any liability
for any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and
the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers,
employees or representatives is responsible.

 

6.9.
Amendments and Waivers. The terms of this Agreement may be amended, terminated or waived only with the written consent
of the Company, and the holders of at least a majority of the then- outstanding Shares. Any amendment or waiver effected in accordance
with this Subsection 6.9 shall be binding upon the Purchaser and each transferee of the Securities (or the Common Stock
issuable upon conversion thereof), each future holder of all such securities, and the Company.

 

6.10.
Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability
of any other provision.

 

6.11.
Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement,
upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching
or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or
of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a
waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind
or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of
any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative
and not alternative.

 

6.12.
Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with respect
to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the
parties are expressly canceled.

 

[Signature
Page Follows]

 

    	9

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Securities Purchase Agreement as of the date first written above.

 

	 	COMPANY:
	 	 	 
	 	CROE,
    INC.
	 	 	 
	 	By:	 
	 	 	Michael
    Poutre, Chief Executive Officer

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Securities Purchase Agreement as of the date first written above.

 

	 	PURCHASER:
	 	 
	 	By:
    _________________________________________________
	 	 
	 	Print
    Name: ___________________________________________
	 	 
	 	Title:
    N/A_____________________________________________
	 	 
	 	Investment
    Amount: ____________________________________
	 	 
	 	No.
    of Shares Purchased at $2.00 per share: ___________________
	 	 
	 	No.
    of Shares underlying Warrant:__________________________
	 	 
	 	Address:
    _____________________________________________
	 	              
     _____________________________________________
	 	               
    _____________________________________________
	 	 
	 	Facsimile:
    ____________________________________________
	 	E-mail:
    _______________________________________________WARRANT

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE,
SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE
UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION
AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND,
IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.

 

Warrant
Certificate No.: _____________

 

Original
Issue Date: September __, 2017

 

FOR
VALUE RECEIVED, Croe, Inc., a Utah corporation (the “Company”), hereby certifies that [__________________],
or its registered assigns (the “Holder”) is entitled to purchase from the Company [____________] duly authorized,
validly issued, fully paid and nonassessable shares of Common Stock at a purchase price per share of $2.00 (subject to adjustment
as provided herein, the “Exercise Price”), all subject to the terms, conditions and adjustments set forth below
in this Warrant. Certain capitalized terms used herein are defined in Section 1 hereof.

 

This
Warrant has been issued pursuant to the terms of the Securities purchase Agreement, dated as of September __, 2017 (the “Purchase
Agreement”), between the Company and the Holder.

 

1.
Definitions. As used in this Warrant, the following terms have the respective meanings set forth below:

 

“Aggregate
Exercise Price” means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant
is then being exercised pursuant to Section 3 hereof, multiplied by (b) the Exercise Price in effect as of the Exercise
Date in accordance with the terms of this Warrant.

 

“Board”
means the board of directors of the Company.

 

“Business
Day” means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of Los Angeles,
California are authorized or obligated by law or executive order to close.

 

“Common
Stock” means the common stock, par value $0.001 per share, of the Company, and any capital stock into which such Common
Stock shall have been converted, exchanged or reclassified following the date hereof.

 

“Common
Stock Deemed Outstanding” means, at any given time, the number of shares of Common Stock actually outstanding at such
time.

 

“Company”
has the meaning set forth in the preamble.

 

“Convertible
Securities” means any securities (directly or indirectly) convertible into or exchangeable for Common Stock, but excluding
Options.

 

    	 

    	 

    

 

“Excluded
Issuances” means any issuance or sale (or deemed issuance or sale in accordance with Section 4(d)) by the Company after
the Original Issue Date of: (a) shares of Common Stock issued upon the exercise of this Warrant; (b) shares of Common Stock (as
such number of shares is equitably adjusted for subsequent stock splits, stock combinations, stock dividends and recapitalizations)
issued directly or upon the exercise of Options to directors, officers, employees, or consultants of the Company in connection
with their service as directors of the Company, their employment by the Company or their retention as consultants by the Company,
in each case authorized by the Board and issued pursuant to the Company’s 2017 Equity Incentive Plan, as amended from time
to time; (c) shares of Common Stock issued upon the conversion or exercise of Options (other than Options covered by clause (b)
above) or Convertible Securities issued prior to the Original Issue Date, provided that such securities are not amended
after the date hereof to increase the number of shares of Common Stock issuable thereunder or to lower the exercise or conversion
price thereof; (d) shares of Common Stock, Options or Convertible Securities issued (i) to persons in connection with a joint
venture, strategic alliance or other commercial relationship with such person (including persons that are customers, suppliers
and strategic partners of the Company) relating to the operation of the Company’s business and not for the primary purpose
of raising equity capital, (ii) in connection with a transaction in which the Company, directly or indirectly, acquires another
business or its tangible or intangible assets, or (iii) to lenders as equity kickers in connection with debt financings of the
Company, in each case where such transactions have been approved by the Board; or (e) shares of Common Stock in an offering for
cash for the account of the Company that is underwritten on a firm commitment basis and is registered with the Securities and
Exchange Commission under the Securities Act of 1933, as amended.

 

“Exercise
Date” means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth
in Section 3 shall have been satisfied at or prior to 5:00 p.m., Pacific time, on a Business Day, including, without limitation,
the receipt by the Company of the Exercise Notice, the Warrant and the Aggregate Exercise Price.

 

“Exercise
Notice” has the meaning set forth in Section 3(a)(i).

 

“Exercise
Period” has the meaning set forth in Section 2.

 

“Exercise
Price” has the meaning set forth in the preamble.

 

“Fair
Market Value” means, as of any particular date: (a) the volume weighted average of the closing sales prices of the Common
Stock for such day on all domestic securities exchanges on which the Common Stock may at the time be listed; (b) if there have
been no sales of the Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices
for the Common Stock on all such exchanges at the end of such day; (c) if on any such day the Common Stock is not listed on a
domestic securities exchange, the closing sales price of the Common Stock as quoted on the OTC Bulletin Board, the Pink OTC Markets
or similar quotation system or association for such day; or (d) if there have been no sales of the Common Stock on the OTC Bulletin
Board, the Pink OTC Markets or similar quotation system or association on such day, the average of the highest bid and lowest
asked prices for the Common Stock quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association
at the end of such day; in each case, averaged over twenty (20) consecutive Business Days ending on the Business Day immediately
prior to the day as of which “Fair Market Value” is being determined; provided, that if the Common Stock is
listed on any domestic securities exchange, the term “Business Day” as used in this sentence means Business Days on
which such exchange is open for trading. If at any time the Common Stock is not listed on any domestic securities exchange or
quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association, the “Fair Market Value”
of the Common Stock shall be the fair market value per share as determined jointly by the Board and the Holder; provided,
that if the Board and the Holder are unable to agree on the fair market value per share of the Common Stock within a reasonable
period of time (not to exceed three (3) days from the Company’s receipt of the Exercise Notice), such fair market value
shall be determined by a nationally recognized investment banking, accounting or valuation firm engaged by the Company). The determination
of such firm shall be final and conclusive, and the fees and expenses of such valuation firm shall be borne equally by the Company
and the Holder.

 

“Holder”
has the meaning set forth in the preamble.

 

“Options”
means any warrants or other rights or options to subscribe for or purchase Common Stock or Convertible Securities.

 

    	 

    	 

    

 

“Original
Issue Date” means the date on which the Warrant was issued by the Company pursuant to the Purchase Agreement.

 

“OTC
Bulletin Board” means the Financial Industry Regulatory Authority OTC Bulletin Board electronic inter-dealer quotation
system.

 

“Person”
means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated
organization or government or department or agency thereof.

 

“Pink
OTC Markets” means the OTC Markets Group Inc. electronic inter-dealer quotation system, including OTCQX, OTCQB and OTC
Pink.

 

“Purchase
Agreement” has the meaning set forth in the preamble.

 

“Warrant”
means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.

 

“Warrant
Shares” means the shares of Common Stock or other capital stock of the Company then purchasable upon exercise of this
Warrant in accordance with the terms of this Warrant.

 

2.
Term of Warrant. Subject to the terms and conditions hereof, at any time or from time to time after the date hereof and
prior to 5:00 p.m., Pacific time, on the [NUMBER] anniversary of the date hereof or, if such day is not a Business Day, on the
next preceding Business Day (the “Exercise Period”), the Holder of this Warrant may exercise this Warrant for
all or any part of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).

 

3.
Exercise of Warrant.

 

(a)
Exercise Procedure. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or
any part of the unexercised Warrant Shares, upon:

 

(i)
surrender of this Warrant to the Company at its then principal executive offices (or an indemnification undertaking with respect
to this Warrant in the case of its loss, theft or destruction), together with an Exercise Notice in the form attached hereto as
Exhibit A (each, an “Exercise Notice”), duly completed (including specifying the number of Warrant Shares
to be purchased) and executed; and

 

(ii)
payment to the Company of the Aggregate Exercise Price in accordance with Section 3(b).

 

(b)
Payment of the Aggregate Exercise Price. Payment of the Aggregate Exercise Price shall be made, at the option of the Holder as
expressed in the Exercise Notice, by the following methods:

 

(i)
by delivery to the Company of a certified or official bank check payable to the order of the Company or by wire transfer of immediately
available funds to an account designated in writing by the Company, in the amount of such Aggregate Exercise Price;

 

(ii)
by instructing the Company to issue Warrant Shares then issuable upon exercise of all or any part of this Warrant on a net basis
such that, without payment of any cash consideration or other immediately available funds, the Holder shall surrender this Warrant
in exchange for the number of Warrant Shares as is computed using the following formula:

 

    	 

    	 

    

 

Where:

 

X
= the number of Warrant Shares to be issued to the Holder.

 

Y
= the total number of Warrant Shares for which the Holder has elected to exercise this Warrant pursuant to Section 3(a).

 

A
= the Fair Market Value of one Warrant Share as of the applicable Exercise Date.

 

B
= the Exercise Price in effect under this Warrant as of the applicable Exercise Date.

 

X
= Y(A - B) ÷ A; or

 

(iii)
any combination of the foregoing.

 

(c)
Delivery of Stock Certificates. Upon receipt by the Company of the Exercise Notice, surrender of this Warrant and payment of the
Aggregate Exercise Price (in accordance with Section 3(b) hereof), the Company shall, as promptly as practicable, and in any event
within five (5) Business Days thereafter, execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder
a certificate or certificates representing the Warrant Shares issuable upon such exercise, together with cash in lieu of any fraction
of a share, as provided in Section 3(d) hereof. The stock certificate or certificates so delivered shall be, to the extent possible,
in such denomination or denominations as the exercising Holder shall reasonably request in the Exercise Notice and shall be registered
in the name of the Holder or, subject to compliance with Section 5 below, such other Person’s name as shall be designated
in the Exercise Notice. This Warrant shall be deemed to have been exercised and such certificate or certificates of Warrant Shares
shall be deemed to have been issued, and the Holder or any other Person so designated to be named therein shall be deemed to have
become a holder of record of such Warrant Shares for all purposes, as of the Exercise Date.

 

(d)
Fractional Shares. The Company shall not be required to issue a fractional Warrant Share upon exercise of any Warrant. As to any
fraction of a Warrant Share that the Holder would otherwise be entitled to purchase upon such exercise, the Company shall pay
to such Holder an amount in cash (by delivery of a certified or official bank check or by wire transfer of immediately available
funds) equal to the product of (i) such fraction multiplied by (ii) the Fair Market Value of one Warrant Share on the Exercise
Date.

 

(e)
Delivery of New Warrant. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised,
the Company shall, at the time of delivery of the certificate or certificates representing the Warrant Shares being issued in
accordance with Section 3(c) hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired
and unexercised Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.

 

(f)
Valid Issuance of Warrant and Warrant Shares; Payment of Taxes. With respect to the exercise of this warrant, the Company hereby
represents, covenants and agrees:

 

(i)
This Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized
and validly issued.

 

(ii)
All Warrant Shares issuable upon the exercise of this Warrant pursuant to the terms hereof shall be, upon issuance, and the Company
shall take all such actions as may be necessary or appropriate in order that such Warrant Shares are, validly issued, fully paid
and non-assessable, issued without violation of any preemptive or similar rights of any stockholder of the Company and free and
clear of all taxes, liens and charges.

 

(iii)
The Company shall take all such actions as may be necessary to ensure that all such Warrant Shares are issued without violation
by the Company of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which
shares of Common Stock or other securities constituting Warrant Shares may be listed at the time of such exercise (except for
official notice of issuance which shall be immediately delivered by the Company upon each such issuance).

 

    	 

    	 

    

 

(iv)
The Company shall use its best efforts to cause the Warrant Shares, immediately upon such exercise, to be listed on any domestic
securities exchange upon which shares of Common Stock or other securities constituting Warrant Shares are listed at the time of
such exercise.

 

(v)
The Company shall pay all expenses in connection with, and all taxes and other governmental charges that may be imposed with respect
to, the issuance or delivery of Warrant Shares upon exercise of this Warrant; provided, that the Company shall not be required
to pay any tax or governmental charge that may be imposed with respect to any applicable withholding or the issuance or delivery
of the Warrant Shares to any Person other than the Holder, and no such issuance or delivery shall be made unless and until the
Person requesting such issuance has paid to the Company the amount of any such tax, or has established to the satisfaction of
the Company that such tax has been paid.

 

(g)
Reservation of Shares. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized
but unissued Common Stock or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise
of this Warrant, the maximum number of Warrant Shares issuable upon the exercise of this Warrant, and the par value per Warrant
Share shall at all times be less than or equal to the applicable Exercise Price. The Company shall not increase the par value
of any Warrant Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, and shall take all
such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable
shares of Common Stock upon the exercise of this Warrant.

 

4.
Adjustment to Exercise Price and Number of Warrant Shares. In order to prevent dilution of the purchase rights granted
under this Warrant, the Exercise Price and the number of Warrant Shares issuable upon exercise of this Warrant shall be subject
to adjustment from time to time as provided in this Section 4 (in each case, after taking into consideration any prior adjustments
pursuant to this Section 4).

 

(a)
Adjustment to Exercise Price Upon Issuance of Common Stock. Except as provided in Section 4(c) and except in the case of an event
described in either Section 4(e) or Section 4(f), if the Company shall, at any time or from time to time after the Original Issue
Date, issue or sell, or in accordance with Section 4(d) is deemed to have issued or sold, any shares of Common Stock without consideration
or for consideration per share less than the Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance
or sale), then immediately upon such issuance or sale (or deemed issuance or sale), the Exercise Price in effect immediately prior
to such issuance or sale (or deemed issuance or sale) shall be reduced (and in no event increased) to an Exercise Price equal
to the quotient obtained by dividing:

 

(i)
the sum of (A) the product obtained by multiplying the Common Stock Deemed Outstanding immediately prior to such issuance or sale
(or deemed issuance or sale) by the Exercise Price then in effect plus (B) the aggregate consideration, if any, received by the
Company upon such issuance or sale (or deemed issuance or sale); by

 

(ii)
the sum of (A) the Common Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) plus
(B) the aggregate number of shares of Common Stock issued or sold (or deemed issued or sold) by the Company in such issuance or
sale (or deemed issuance or sale).

 

(b)
Adjustment to Number of Warrant Shares Upon Adjustment to Exercise Price. Upon any and each adjustment of the Exercise Price as
provided in Section 4(a), the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to any such
adjustment shall be increased to a number of Warrant Shares equal to the quotient obtained by dividing:

 

(i)
the product of (A) the Exercise Price in effect immediately prior to any such adjustment multiplied by (B) the number of Warrant
Shares issuable upon exercise of this Warrant immediately prior to any such adjustment; by

 

(ii)
the Exercise Price resulting from such adjustment.

 

    	 

    	 

    

 

(c)
Exceptions To Adjustment Upon Issuance of Common Stock. Anything herein to the contrary notwithstanding, there shall be no adjustment
to the Exercise Price or the number of Warrant Shares issuable upon exercise of this Warrant with respect to any Excluded Issuance.

 

(d)
Effect of Certain Events on Adjustment to Exercise Price. For purposes of determining the adjusted Exercise Price under Section
4(a) hereof, the following shall be applicable:

 

(i)
Issuance of Options. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner grant
or sell (whether directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to
convert or exchange any Convertible Securities issuable upon the exercise of such Options are immediately exercisable, and the
price per share (determined as provided in this paragraph and in Section 4(d)(v) ) for which Common Stock is issuable upon the
exercise of such Options or upon the conversion or exchange of Convertible Securities issuable upon the exercise of such Options
is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Options, then the total
maximum number of shares of Common Stock issuable upon the exercise of such Options or upon conversion or exchange of the total
maximum amount of Convertible Securities issuable upon the exercise of such Options shall be deemed to have been issued as of
the date of granting or sale of such Options (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise
Price under Section 4(a)), at a price per share equal to the quotient obtained by dividing (A) the sum (which sum shall constitute
the applicable consideration received for purposes of Section 4(a)) of (x) the total amount, if any, received or receivable by
the Company as consideration for the granting or sale of all such Options, plus (y) the minimum aggregate amount of additional
consideration payable to the Company upon the exercise of all such Options, plus (z), in the case of such Options which relate
to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable to the Company upon the issuance
or sale of all such Convertible Securities and the conversion or exchange of all such Convertible Securities, by (B) the total
maximum number of shares of Common Stock issuable upon the exercise of all such Options or upon the conversion or exchange of
all Convertible Securities issuable upon the exercise of all such Options. Except as otherwise provided in Section 4(d)(iii),
no further adjustment of the Exercise Price shall be made upon the actual issuance of Common Stock or of Convertible Securities
upon exercise of such Options or upon the actual issuance of Common Stock upon conversion or exchange of Convertible Securities
issuable upon exercise of such Options.

 

(ii)
Issuance of Convertible Securities. If the Company shall, at any time or from time to time after the Original Issue Date, in any
manner grant or sell (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the
right to convert or exchange any such Convertible Securities is immediately exercisable, and the price per share (determined as
provided in this paragraph and in Section 4(d)(v) ) for which Common Stock is issuable upon the conversion or exchange of such
Convertible Securities is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such
Convertible Securities, then the total maximum number of shares of Common Stock issuable upon conversion or exchange of the total
maximum amount of such Convertible Securities shall be deemed to have been issued as of the date of granting or sale of such Convertible
Securities (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price pursuant to Section
4(a)), at a price per share equal to the quotient obtained by dividing (A) the sum (which sum shall constitute the applicable
consideration received for purposes of Section 4(a)) of (x) the total amount, if any, received or receivable by the Company as
consideration for the granting or sale of such Convertible Securities, plus (y) the minimum aggregate amount of additional consideration,
if any, payable to the Company upon the conversion or exchange of all such Convertible Securities, by (B) the total maximum number
of shares of Common Stock issuable upon the conversion or exchange of all such Convertible Securities. Except as otherwise provided
in Section 4(d)(iii), no further adjustment of the Exercise Price shall be made upon the actual issuance of Common Stock upon
conversion or exchange of such Convertible Securities or the issue or sale of Convertible Securities upon exercise of any Options
to purchase any such Convertible Securities for which adjustments of the Exercise Price have been made pursuant to the other provisions
of this Section 4(d).

 

    	 

    	 

    

 

(iii)
Change in Terms of Options or Convertible Securities. Upon any change in any of (A) the total amount received or receivable by
the Company as consideration for the granting or sale of any Options or Convertible Securities referred to in Section 4(d)(i)
or Section 4(d)(ii) hereof, (B) the minimum aggregate amount of additional consideration, if any, payable to the Company upon
the exercise of any Options or upon the issuance, conversion or exchange of any Convertible Securities referred to in Section
4(d)(i) or Section 4(d)(ii) hereof, (C) the rate at which Convertible Securities referred to in Section 4(d)(i) or Section 4(d)(ii)
hereof are convertible into or exchangeable for Common Stock, or (D) the maximum number of shares of Common Stock issuable in
connection with any Options referred to in Section 4(d)(i) hereof or any Convertible Securities referred to in Section 4(d)(ii)
hereof (in each case, other than in connection with an Excluded Issuance), then (whether or not the original issuance or sale
of such Options or Convertible Securities resulted in an adjustment to the Exercise Price pursuant to this Section 4) the Exercise
Price in effect at the time of such change shall be adjusted or readjusted, as applicable, to the Exercise Price which would have
been in effect at such time pursuant to the provisions of this Section 4 had such Options or Convertible Securities still outstanding
provided for such changed consideration, conversion rate or maximum number of shares, as the case may be, at the time initially
granted, issued or sold, but only if as a result of such adjustment or readjustment the Exercise Price then in effect is reduced,
and the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment or readjustment
shall be correspondingly adjusted or readjusted pursuant to the provisions of Section 4(b).

 

(iv)
Treatment of Expired or Terminated Options or Convertible Securities. Upon the expiration or termination of any unexercised Option
(or portion thereof) or any unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either
upon its original issuance or upon a revision of its terms) was made pursuant to this Section 4 (including without limitation
upon the redemption or purchase for consideration of all or any portion of such Option or Convertible Security by the Company),
the Exercise Price then in effect hereunder shall forthwith be changed pursuant to the provisions of this Section 4 to the Exercise
Price which would have been in effect at the time of such expiration or termination had such unexercised Option (or portion thereof)
or unconverted or unexchanged Convertible Security (or portion thereof), to the extent outstanding immediately prior to such expiration
or termination, never been issued.

 

(v)
Record Date. For purposes of any adjustment to the Exercise Price or the number of Warrant Shares in accordance with this Section
4, in case the Company shall take a record of the holders of its Common Stock for the purpose of entitling them (A) to receive
a dividend or other distribution payable in Common Stock, Options or Convertible Securities or (B) to subscribe for or purchase
Common Stock, Options or Convertible Securities, then such record date shall be deemed to be the date of the issue or sale of
the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other
distribution or the date of the granting of such right of subscription or purchase, as the case may be; provided, that
if before the distribution to its holders of Common Stock the Company legally abandons its plan to pay or deliver such dividend,
distribution, subscription or purchase rights, then thereafter no adjustment shall be required by the taking of such record and
any such adjustment previously made in respect thereof shall be rescinded and annulled.

 

(vi)
Treasury Shares. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by
or for the account of the Company or any of its wholly-owned subsidiaries, and the disposition of any such shares (other than
the cancellation or retirement thereof or the transfer of such shares among the Company and its wholly-owned subsidiaries) shall
be considered an issue or sale of Common Stock for the purpose of this Section 4.

 

(e)
Adjustment to Exercise Price and Warrant Shares Upon Dividend, Subdivision or Combination of Common Stock. If the Company shall,
at any time or from time to time after the Original Issue Date, (i) pay a dividend or make any other distribution upon the Common
Stock or any other capital stock of the Company payable in shares of Common Stock or in Options or Convertible Securities, or
(ii) subdivide (by any stock split, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number
of shares, the Exercise Price in effect immediately prior to any such dividend, distribution or subdivision shall be proportionately
reduced and the number of Warrant Shares issuable upon exercise of this Warrant shall be proportionately increased. If the Company
at any time combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller
number of shares, the Exercise Price in effect immediately prior to such combination shall be proportionately increased and the
number of Warrant Shares issuable upon exercise of this Warrant shall be proportionately decreased. Any adjustment under this
Section 4(e) shall become effective at the close of business on the date the dividend, subdivision or combination becomes effective.

 

    	 

    	 

    

 

(f)
Adjustment to Exercise Price and Warrant Shares Upon Reorganization, Reclassification, Consolidation or Merger. In the event of
any (i) capital reorganization of the Company, (ii) reclassification of the stock of the Company (other than a change in par value
or from par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up
or combination of shares), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially
all of the Company’s assets to another Person or (v) other similar transaction (other than any such transaction covered
by Section 4(e)), in each case which entitles the holders of Common Stock to receive (either directly or upon subsequent liquidation)
stock, securities or assets with respect to or in exchange for Common Stock, each Warrant shall, immediately after such reorganization,
reclassification, consolidation, merger, sale or similar transaction, remain outstanding and shall thereafter, in lieu of or in
addition to (as the case may be) the number of Warrant Shares then exercisable under this Warrant, be exercisable for the kind
and number of shares of stock or other securities or assets of the Company or of the successor Person resulting from such transaction
to which the Holder would have been entitled upon such reorganization, reclassification, consolidation, merger, sale or similar
transaction if the Holder had exercised this Warrant in full immediately prior to the time of such reorganization, reclassification,
consolidation, merger, sale or similar transaction and acquired the applicable number of Warrant Shares then issuable hereunder
as a result of such exercise (without taking into account any limitations or restrictions on the exercisability of this Warrant);
and, in such case, appropriate adjustment (in form and substance satisfactory to the Holder) shall be made with respect to the
Holder’s rights under this Warrant to insure that the provisions of this Section 4 hereof shall thereafter be applicable,
as nearly as possible, to this Warrant in relation to any shares of stock, securities or assets thereafter acquirable upon exercise
of this Warrant (including, in the case of any consolidation, merger, sale or similar transaction in which the successor or purchasing
Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share for the Common Stock reflected
by the terms of such consolidation, merger, sale or similar transaction, and a corresponding immediate adjustment to the number
of Warrant Shares acquirable upon exercise of this Warrant without regard to any limitations or restrictions on exercise, if the
value so reflected is less than the Exercise Price in effect immediately prior to such consolidation, merger, sale or similar
transaction). The provisions of this Section 4(f) shall similarly apply to successive reorganizations, reclassifications, consolidations,
mergers, sales or similar transactions. The Company shall not effect any such reorganization, reclassification, consolidation,
merger, sale or similar transaction unless, prior to the consummation thereof, the successor Person (if other than the Company)
resulting from such reorganization, reclassification, consolidation, merger, sale or similar transaction, shall assume, by written
instrument substantially similar in form and substance to this Warrant and satisfactory to the Holder, the obligation to deliver
to the Holder such shares of stock, securities or assets which, in accordance with the foregoing provisions, such Holder shall
be entitled to receive upon exercise of this Warrant.

 

(g)
Certificate as to Adjustment.

 

(i)
As promptly as reasonably practicable following any adjustment of the Exercise Price, but in any event not later than five (5)
Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable
detail such adjustment and the facts upon which it is based and certifying the calculation thereof.

 

(ii)
As promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event
not later than five (5) Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer
certifying the Exercise Price then in effect and the number of Warrant Shares or the amount, if any, of other shares of stock,
securities or assets then issuable upon exercise of the Warrant.

 

    	 

    	 

    

 

5.
Transfer of Warrant. Subject to the transfer conditions referred to in the legend endorsed hereon, this Warrant and all
rights hereunder are transferable, in whole or in part, by the Holder without charge to the Holder, upon surrender of this Warrant
to the Company at its then principal executive offices with a properly completed and duly executed assignment, together with funds
sufficient to pay any transfer taxes described in Section 3(f)(v) in connection with the making of such transfer. Upon such compliance,
surrender and delivery and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the
name of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly be cancelled.

 

6.
Holder Not Deemed a Stockholder; Limitations on Liability. Except as otherwise specifically provided herein, prior to the
issuance to the Holder of the Warrant Shares to which the Holder is then entitled to receive upon the due exercise of this Warrant,
the Holder shall not be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the Company
for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, as such, any of the rights
of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization,
issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive
dividends or subscription rights, or otherwise. In addition, nothing contained in this Warrant shall be construed as imposing
any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the
Company, whether such liabilities are asserted by the Company or by creditors of the Company.

 

7.
Replacement on Loss; Division and Combination.

 

(a)
Replacement of Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written
indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon
surrender of such Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Holder,
in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant Shares as the Warrant so lost,
stolen, mutilated or destroyed; provided, that, in the case of mutilation, no indemnity shall be required if this Warrant
in identifiable form is surrendered to the Company for cancellation.

 

(b)
Division and Combination of Warrant. Subject to compliance with the applicable provisions of this Warrant as to any transfer or
other assignment which may be involved in such division or combination, this Warrant may be divided or, following any such division
of this Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its
then principal executive offices, together with a written notice specifying the names and denominations in which new Warrants
are to be issued, signed by the respective Holders or their agents or attorneys. Subject to compliance with the applicable provisions
of this Warrant as to any transfer or assignment which may be involved in such division or combination, the Company shall at its
own expense execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance
with such notice. Such new Warrant or Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable
in the aggregate for an equivalent number of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such
notice.

 

8.
Compliance with the Securities Act.

 

(a)
Agreement to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant, agrees to comply in all respects
with the provisions of this Section 8 and the restrictive legend requirements set forth on the face of this Warrant and further
agrees that such Holder shall not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise
hereof except under circumstances that will not result in a violation of the Securities Act of 1933, as amended (the “Securities
Act”). This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Securities
Act) shall be stamped or imprinted with a legend in substantially the following form:

 

“THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE,
SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE
UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION
AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND,
IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”

 

    	 

    	 

    

 

(b)
Representations of the Holder. In connection with the issuance of this Warrant, the Holder specifically represents, as of the
date hereof, to the Company by acceptance of this Warrant as follows:

 

(i)
The Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act. The Holder is acquiring this Warrant and the Warrant Shares to be issued upon exercise hereof for investment for its own
account and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the
Warrant Shares, except pursuant to sales registered or exempted under the Securities Act.

 

(ii)
The Holder understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not
involving a public offering and that, under such laws and applicable regulations, such securities may be resold without registration
under the Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule
144 under the Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities
Act.

 

(iii)
The Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period, and has such
knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment
in the Warrant and the Warrant Shares. The Holder has had an opportunity to ask questions and receive answers from the Company
regarding the terms and conditions of the offering of the Warrant and the business, properties, prospects and financial condition
of the Company.

 

9.
Warrant Register. The Company shall keep and properly maintain at its principal executive offices books for the registration
of the Warrant and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on
such register as the Holder thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except
any assignment, division, combination or other transfer of the Warrant effected in accordance with the provisions of this Warrant.

 

10.
Notices. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing
and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by
the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by e-mail of a PDF
document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day
if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered
mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses indicated
below (or at such other address for a party as shall be specified in a notice given in accordance with this Section 10).

 

    	 

    	 

    

 

	If
        to the Company:

         

         
	23805
        Stuart Ranch Road, Suite 235

        

        Malibu,
        CA 90265

        

        E-mail:
        [mike@thecryptocompany.com]

        

        Attention:
        Chief Executive Officer

         

        

	with
        a copy to:

         

         
	Drinker
        Biddle & Reath LLP

        

        E-mail:
        jr.lanis@dbr.com

        

        Attention:
        Alan A. Lanis, Jr.

        

         

	If
        to the Holder:

         

         
	[HOLDER
        ADDRESS]

        

        E-mail:
        [E-MAIL ADDRESS]

        

        Attention:[TITLE
        OF OFFICER TO RECEIVE NOTICES]

        

         

 

11.
Cumulative Remedies. Except to the extent expressly provided herein to the contrary, the rights and remedies provided in
this Warrant are cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or
remedies available at law, in equity or otherwise.

 

12.
Equitable Relief. Each of the Company and the Holder acknowledges that a breach or threatened breach by such party of any
of its obligations under this Warrant would give rise to irreparable harm to the other party hereto for which monetary damages
would not be an adequate remedy and hereby agrees that in the event of a breach or a threatened breach by such party of any such
obligations, the other party hereto shall, in addition to any and all other rights and remedies that may be available to it in
respect of such breach, be entitled to equitable relief, including a restraining order, an injunction, specific performance and
any other relief that may be available from a court of competent jurisdiction.

 

13.
Entire Agreement. This Warrant, together with the Purchase Agreement, constitutes the sole and entire agreement of the
parties to this Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings
and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the statements
in the body of this Warrant and the Purchase Agreement, the statements in the body of this Warrant shall control.

 

14.
Successor and Assigns. This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit
of the parties hereto and the successors of the Company and the successors and permitted assigns of the Holder. Such successors
and/or permitted assigns of the Holder shall be deemed to be a Holder for all purposes hereunder.

 

15.
No Third-Party Beneficiaries. This Warrant is for the sole benefit of the Company and the Holder and their respective successors
and, in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon
any other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant.

 

16.
Headings. The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.

 

17.
Amendment and Modification; Waiver. Except as otherwise provided herein, this Warrant may only be amended, modified or
supplemented by an agreement in writing signed by each party hereto. No waiver by the Company or the Holder of any of the provisions
hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall
operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver,
whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay
in exercising, any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a waiver thereof;
nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise
thereof or the exercise of any other right, remedy, power or privilege.

 

    	 

    	 

    

 

18.
Severability. If any term or provision of this Warrant is invalid, illegal or unenforceable in any jurisdiction, such invalidity,
illegality or unenforceability shall not affect any other term or provision of this Warrant or invalidate or render unenforceable
such term or provision in any other jurisdiction.

 

19.
Governing Law. This Warrant shall be governed by and construed in accordance with the internal laws of the State of Nevada
without giving effect to any choice or conflict of law provision or rule (whether of the State of Nevada or any other jurisdiction)
that would cause the application of laws of any jurisdiction other than those of the State of Nevada.

 

20.
Submission to Jurisdiction. Any legal suit, action or proceeding arising out of or based upon this Warrant or the transactions
contemplated hereby may be instituted in the federal courts of the United States of America or the courts of the State of Nevada
in each case located in the city of Las Vegas and County of Clark, and each party irrevocably submits to the exclusive jurisdiction
of such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by certified or registered
mail to such party’s address set forth herein shall be effective service of process for any suit, action or other proceeding
brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit,
action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such
suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

 

21.
Waiver of Jury Trial. Each party acknowledges and agrees that any controversy which may arise under this Warrant is likely
to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it
may have to a trial by jury in respect of any legal action arising out of or relating to this Warrant or the transactions contemplated
hereby.

 

22.
Counterparts. This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which
together shall be deemed to be one and the same agreement. A signed copy of this Warrant delivered by e-mail or other means of
electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.

 

23.
No Strict Construction. This Warrant shall be construed without regard to any presumption or rule requiring construction
or interpretation against the party drafting an instrument or causing any instrument to be drafted.

 

IN
WITNESS WHEREOF, the Company has duly executed this Warrant on the Original Issue Date.

 

	 	Croe,
Inc.

	 	 
	 	By:

        

        
	

         

        

        

	 	Name:	Michael
        Poutre
	 	Title:	Chief
        Executive Officer

 

	Accepted
        and agreed,

        

	 
	[HOLDER NAME]

	 

        

        

	 	 
	By:
	 	 
	Name:	 	 
	

        

        Title:

        
	 	 

 

    	 

    	 

    

 

Exhibit
A 

 

Form
of Exercise Notice  

(To
be signed only on exercise of Warrant)

 

TO:
Croe, Inc.

Attention:
Chief Executive Officer

 

The
undersigned, pursuant to the provisions set forth in the attached Warrant (No. ________), hereby irrevocably elects to purchase
(check applicable box):

 

__________shares
of the Common Stock covered by such Warrant; or

 

__________the
maximum number of shares of Common Stock covered by such Warrant pursuant to the cashless exercise procedure set forth in Section
3(b).

 

The
undersigned herewith makes payment of the full Exercise Price for such shares at the price per share provided for in such Warrant,
which is $ _____. Such payment takes the form of (check applicable box or boxes):

 

$
________ in lawful money of the United States; and/or

 

__________the
cancellation of such portion of the attached Warrant as is exercisable for a total of ______ shares of Common Stock (using a Current
Fair Market Value of $ _______ per share for purposes of this calculation); and/or

 

__________the
cancellation of such number of shares of Common Stock as is necessary, in accordance with the formula set forth in Section 3(b),
to exercise this Warrant with respect to the maximum number of shares of Common Stock purchasable pursuant to the cashless exercise
procedure set forth in Section 3(b).

 

The
undersigned requests that the certificates for such shares be issued in the name of, and delivered to the following person:

 

	_______________________________
	 
	_______________________________
	 
	_______________________________
	 
	_______________________________

 

The
undersigned represents and warrants that all offers and sales by the undersigned of the securities issuable upon exercise of the
Warrant shall be made pursuant to registration of the Common Stock under the Securities Act of 1933, as amended (the “Securities
Act”), or pursuant to an exemption from registration under the Securities Act.

 

	 ______________	___________________________________
	(Date)	(Signature
must conform to name of Holder as specified on the face of the Warrant)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]